Celldex, Shire in drug-sector spotlight
May 18, 2011 at 10:50 AM EDT
Celldex Therapeutics tumble after the biotech group prices a public offering almost 20% below the stock’s prior-day close. Shire climbs on deal news.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.